125 related articles for article (PubMed ID: 14996553)
1. Trichloroethanol enhances the activity of recombinant human TREK-1 and TRAAK channels.
Harinath S; Sikdar SK
Neuropharmacology; 2004 Apr; 46(5):750-60. PubMed ID: 14996553
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human TREK-1 channels by caffeine and theophylline.
Harinath S; Sikdar SK
Epilepsy Res; 2005 May; 64(3):127-35. PubMed ID: 15927451
[TBL] [Abstract][Full Text] [Related]
3. 2,2,2-trichloroethanol activates a nonclassical potassium channel in cerebrovascular smooth muscle and dilates the middle cerebral artery.
Parelkar NK; Silswal N; Jansen K; Vaughn J; Bryan RM; Andresen J
J Pharmacol Exp Ther; 2010 Mar; 332(3):803-10. PubMed ID: 19955488
[TBL] [Abstract][Full Text] [Related]
4. Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection.
Miller P; Kemp PJ; Lewis A; Chapman CG; Meadows HJ; Peers C
J Physiol; 2003 Apr; 548(Pt 1):31-7. PubMed ID: 12611912
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotics inhibit TREK but not TRAAK channels.
Thümmler S; Duprat F; Lazdunski M
Biochem Biophys Res Commun; 2007 Mar; 354(1):284-9. PubMed ID: 17222806
[TBL] [Abstract][Full Text] [Related]
6. Expression of thermosensitive two-pore domain K+ channels in human keratinocytes cell line HaCaT cells.
Kang D; Kim SH; Hwang EM; Kwon OS; Yang HY; Kim ES; Choi TH; Park JY; Hong SG; Han J
Exp Dermatol; 2007 Dec; 16(12):1016-22. PubMed ID: 18031461
[TBL] [Abstract][Full Text] [Related]
7. The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK.
Meadows HJ; Chapman CG; Duckworth DM; Kelsell RE; Murdock PR; Nasir S; Rennie G; Randall AD
Brain Res; 2001 Feb; 892(1):94-101. PubMed ID: 11172753
[TBL] [Abstract][Full Text] [Related]
8. The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK.
Duprat F; Lesage F; Patel AJ; Fink M; Romey G; Lazdunski M
Mol Pharmacol; 2000 May; 57(5):906-12. PubMed ID: 10779373
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical colocalization of TREK-1, TREK-2 and TRAAK with TRP channels in the trigeminal ganglion cells.
Yamamoto Y; Hatakeyama T; Taniguchi K
Neurosci Lett; 2009 Apr; 454(2):129-33. PubMed ID: 19429069
[TBL] [Abstract][Full Text] [Related]
10. Over-expressed human TREK-1 inhibits CHO cell proliferation via inhibiting PKA and p38 MAPK pathways and subsequently inducing G1 arrest.
Zhang M; Yin HJ; Wang WP; Li J; Wang XL
Acta Pharmacol Sin; 2016 Sep; 37(9):1190-8. PubMed ID: 27397543
[TBL] [Abstract][Full Text] [Related]
11. Caffeic acid esters activate TREK-1 potassium channels and inhibit depolarization-dependent secretion.
Danthi S; Enyeart JA; Enyeart JJ
Mol Pharmacol; 2004 Mar; 65(3):599-610. PubMed ID: 14978238
[TBL] [Abstract][Full Text] [Related]
12. Identification of native rat cerebellar granule cell currents due to background K channel KCNK5 (TASK-2).
Cotten JF; Zou HL; Liu C; Au JD; Yost CS
Brain Res Mol Brain Res; 2004 Sep; 128(2):112-20. PubMed ID: 15363886
[TBL] [Abstract][Full Text] [Related]
13. Tandem-pore domain potassium channels are functionally expressed in retinal (Müller) glial cells.
Skatchkov SN; Eaton MJ; Shuba YM; Kucheryavykh YV; Derst C; Veh RW; Wurm A; Iandiev I; Pannicke T; Bringmann A; Reichenbach A
Glia; 2006 Feb; 53(3):266-76. PubMed ID: 16265669
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK.
Kang D; Choe C; Kim D
J Physiol; 2005 Apr; 564(Pt 1):103-16. PubMed ID: 15677687
[TBL] [Abstract][Full Text] [Related]
15. Zinc activates TREK-2 potassium channel activity.
Kim JS; Park JY; Kang HW; Lee EJ; Bang H; Lee JH
J Pharmacol Exp Ther; 2005 Aug; 314(2):618-25. PubMed ID: 15857947
[TBL] [Abstract][Full Text] [Related]
16. Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel.
Meadows HJ; Benham CD; Cairns W; Gloger I; Jennings C; Medhurst AD; Murdock P; Chapman CG
Pflugers Arch; 2000 Apr; 439(6):714-22. PubMed ID: 10784345
[TBL] [Abstract][Full Text] [Related]
17. Localization of TREK-1, a two-pore-domain K+ channel in the peripheral vestibular system of mouse and rat.
Nicolas MT; Lesage F; Reyes R; Barhanin J; Demêmes D
Brain Res; 2004 Aug; 1017(1-2):46-52. PubMed ID: 15261098
[TBL] [Abstract][Full Text] [Related]
18. TREK-1 is a novel molecular target in prostate cancer.
Voloshyna I; Besana A; Castillo M; Matos T; Weinstein IB; Mansukhani M; Robinson RB; Cordon-Cardo C; Feinmark SJ
Cancer Res; 2008 Feb; 68(4):1197-203. PubMed ID: 18281496
[TBL] [Abstract][Full Text] [Related]
19. Expression of the mechanosensitive 2PK+ channel TREK-1 in human osteoblasts.
Hughes S; Magnay J; Foreman M; Publicover SJ; Dobson JP; El Haj AJ
J Cell Physiol; 2006 Mar; 206(3):738-48. PubMed ID: 16250016
[TBL] [Abstract][Full Text] [Related]
20. Inhalational anesthetics activate two-pore-domain background K+ channels.
Patel AJ; Honoré E; Lesage F; Fink M; Romey G; Lazdunski M
Nat Neurosci; 1999 May; 2(5):422-6. PubMed ID: 10321245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
